Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tandem Diabetes Care (TNDM) Current Leases (2019 - 2026)

Tandem Diabetes Care filings provide 7 years of Current Leases readings, the most recent being $19.5 million for Q4 2025.

  • On a quarterly basis, Current Leases rose 6.94% to $19.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was $19.5 million, a 6.94% increase, with the full-year FY2025 number at $19.5 million, up 6.94% from a year prior.
  • Current Leases hit $19.5 million in Q4 2025 for Tandem Diabetes Care, down from $21.3 million in the prior quarter.
  • In the past five years, Current Leases ranged from a high of $21.3 million in Q3 2025 to a low of $8.1 million in Q1 2022.
  • Median Current Leases over the past 5 years was $17.2 million (2023), compared with a mean of $15.1 million.
  • Biggest five-year swings in Current Leases: decreased 14.46% in 2022 and later soared 96.15% in 2023.
  • Tandem Diabetes Care's Current Leases stood at $9.3 million in 2021, then surged by 41.41% to $13.1 million in 2022, then skyrocketed by 30.02% to $17.1 million in 2023, then increased by 6.73% to $18.2 million in 2024, then increased by 6.94% to $19.5 million in 2025.
  • The last three reported values for Current Leases were $19.5 million (Q4 2025), $21.3 million (Q3 2025), and $19.9 million (Q2 2025) per Business Quant data.